- In June 2024, the F. Hoffmann-La Roche Ltd company announced the launch of latest product, NucleoMix, 400 mM (100 mM each) designed to meet the specific needs of manufacturers of molecular IVD assays, NucleoMix, 400 mM, is set to advance the field of molecular diagnostics
- In March 2024, Novus International, Inc. acquired U.S.-based enzyme company BioResource International, Inc., gaining ownership of BRI’s products, intellectual property, and facilities. This acquisition will enhance customer service, expand their innovation pipeline, and provide more options for feed additives to support animal health and profitability
